NeoSACT
Phase 2 Completed
29 enrolled
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Phase 2 Completed
20 enrolled 12 charts
Study of DF1001 in Patients With Advanced Solid Tumors
Phase 1/2 Completed
270 enrolled
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors
Phase 1 Completed
28 enrolled
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Phase 3 Completed
203 enrolled 22 charts
Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer
Phase 2 Completed
37 enrolled 8 charts
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer
Phase 2 Completed
10 enrolled 13 charts
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)
Phase 3 Completed
571 enrolled 22 charts
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
Phase 3 Completed
452 enrolled 17 charts
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Phase 3 Completed
190 enrolled 12 charts
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
Phase 1 Completed
23 enrolled 11 charts
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer
Phase 2 Completed
23 enrolled 15 charts
Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
20 enrolled 20 charts
PINBALL
Phase 2 Completed
27 enrolled
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Phase 1/2 Completed
22 enrolled
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
Phase 2/3 Completed
260 enrolled 20 charts
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC
Phase 2 Completed
43 enrolled 8 charts
Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
21 enrolled 17 charts
MK-4830-001
Phase 1 Completed
470 enrolled
Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations
Phase 1 Completed
34 enrolled
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Phase 2 Completed
454 enrolled 23 charts
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
272 enrolled 17 charts
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
Phase 1 Completed
446 enrolled 49 charts
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Phase 2/3 Completed
130 enrolled 8 charts
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Phase 3 Completed
305 enrolled 10 charts
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
Phase 2 Completed
30 enrolled 13 charts
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Phase 3 Completed
3,270 enrolled 16 charts
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Phase 1 Completed
56 enrolled 19 charts
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
Phase 2 Completed
48 enrolled 13 charts
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
Phase 1 Completed
11 enrolled 9 charts
MK-0482-001
Phase 1 Completed
222 enrolled
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
31 enrolled 20 charts
Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients
Phase 2 Completed
50 enrolled
Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2 Completed
31 enrolled 12 charts
KETO-CARE
Phase 1 Completed
20 enrolled
BRIGHT
Phase 2 Completed
108 enrolled
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1/2 Completed
147 enrolled 18 charts
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
Phase 1 Completed
20 enrolled
OPTIMA-II
Phase 2 Completed
72 enrolled 14 charts
Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Phase 2 Completed
34 enrolled 10 charts
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer
Phase 2 Completed
50 enrolled 14 charts
Intravesicular Abraxane for Treatment-Refractory Bladder Cancer
Phase 1/2 Completed
46 enrolled 11 charts
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
Phase 1/2 Completed
79 enrolled
Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 2 Completed
13 enrolled 14 charts
OPTIMA
Phase 2 Completed
62 enrolled 13 charts
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer
Phase 2 Completed
24 enrolled 7 charts
Pharmacological Ascorbate for Lung Cancer
Phase 2 Completed
55 enrolled 10 charts
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
Phase 1 Completed
48 enrolled
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers
Phase 1 Completed
43 enrolled
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies
Phase 1 Completed
35 enrolled